| ADIL | 10-Q/A | bearish | 7/10 | Adial Pharmaceuticals filed Amendment No. 1 to its Form 10-Q for the quarter ended June 30, 2026, primarily to respond t | Oct 20, 2026 |
| GRML | 10-Q/A | neutral | 2/10 | Greenland Mines Ltd filed Amendment No. 1 to its Q1 2026 Form 10-Q to revise certain disclosures in response to SEC comm | Aug 14, 2026 |
| HCWB | 10-Q/A | bearish | 8/10 | Analysis based on filing metadata only — document content was unavailable. HCW Biologics filed an amended 10-Q (10-Q/A) | Aug 14, 2026 |
| PRPH | 10-Q/A | bearish | 8/10 | ProPhase Labs filed Amendment No. 2 to its Q1 2026 10-Q, restating previously issued financial statements to correct mat | Jul 9, 2026 |
| PRPH | 10-Q/A | bearish | 8/10 | ProPhase Labs filed Amendment No. 1 to its Q1 2026 10-Q solely to update the auditor review status, confirming the indep | Jul 7, 2026 |
| CBIO | 10-Q/A | neutral | 3/10 | Crescent Biopharma filed a Form 10-Q/A to add previously omitted Rule 10b5-1 trading arrangement disclosures for its CEO | Jun 22, 2026 |
| QGAI | 10-Q/A | neutral | 3/10 | Quantum Genesis AI Corp. filed an amended 10-Q/A solely to update disclosures in Management's Discussion and Analysis re | Apr 15, 2026 |
| QGAI | 10-Q/A | neutral | 3/10 | Quantum Genesis AI Corp. filed an amended 10-Q/A solely to add disclosure about intellectual property formalization via | Apr 15, 2026 |